is tirzepatide safe for heart patients Cardiovascular outcomes of semaglutide and with type 2 diabetes in clinical practice Heart failure: Weight loss drug

The Bottom Line GLP-1 medications can be highly effective tools for managing obesity and diabetes, but cost remains a significant barrier for many people

The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment

Within the last few years, semaglutide treatments went viral on social media for being labeled as a vanity weight loss method

The sublingual route bypasses the digestive system, which means it may avoid some side effects related to the stomach

According to the STEP-1 clinical trial, patients who consumed semaglutide 2.4 mg once weekly experienced an average weight loss of 15% of their body weight after 68 weeks of treatment